Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Accounts Payables: 2024

Historic Accounts Payables for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $50.0 million.

  • Kura Oncology's Accounts Payables rose 80.67% to $66.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.8 million, marking a year-over-year increase of 80.67%. This contributed to the annual value of $50.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, Kura Oncology's Accounts Payables stood at $50.0 million.
  • Kura Oncology's 5-year Accounts Payables high stood at $50.0 million for FY2024, and its period low was $50.0 million during FY2024.
  • Over the past 1 years, Kura Oncology's median Accounts Payables value was $50.0 million (recorded in 2024), while the average stood at $50.0 million.